AdvaMed Doubled Its Lobbying Spending Over Past Year
Having won repeal of the device tax in late 2019, the group now focuses on CARES Act, user-fee funding
Medtech industry trade group AdvaMed spent more than $2m to help shape US congressional bills in the first quarter of 2020 – more than double what it spent to influence the course of legislation in the first quarter of 2019. Check out our in-depth analysis here.
